Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole.


This study was performed to evaluate whether concomitant treatment with ketoconazole could reduce the clearance of paclitaxel given to ovarian cancer patients. Paclitaxel, 175 mg/m2, was given as a 3-hour continuous intravenous infusion and repeated every 21 days. Initially, ketoconazole, 100 to 1600 mg, was given as a single oral dose 3 hours after… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.